Advertisement

The Roadmap From Allergic Rhinitis to Asthma

  • 8 Accesses

Abstract

Purpose of review

Upper and lower airways display some common characteristic described as a holistic model. Because rhinitis may proceed asthma, it is imperative to understand the mechanisms and risk factors responsible for the progression from rhinitis to asthma.

Recent findings

Subclinical lower airway abnormalities have been observed in patients with rhinitis without asthma. Recent evidence indicates that these patients may have an increased risk of developing asthma. Environmental and genetic factors can contribute to enhance this possibility. The treatments of rhinitis have also been shown to be beneficial to the lower airway, and therefore potentially modify the natural evolution of the atopic march.

Summary

Lower airway disease is a good predictor for the roadmap from rhinitis to asthma. The shared genetic link and environmental factors could be essential for this progression. Albeit treatment of rhinitis has a beneficial effect on lower airway defects, their role to prevent the progression to asthma remains yet to be confirmed.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1

References and Recommended Reading

    Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

    1. 1.

      Bousquet J, Van Cauwenberge P. Khaltaev N and Aria Workshop Group. Allergic rhinitis and its impact on asthma. ARIA workshop report. J Allergy Clin Immunol. 2001;108:S147–334.

    2. 2.

      Cruz A. The “united airways” require an holistic approach to management. Allergy. 2005;60:871–4. https://doi.org/10.1111/j.1398-9995.2005.00858.x.

    3. 3.

      Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy. 2016;9:93–100. https://doi.org/10.2147/JAA.S81541.

    4. 4.

      Boulay ME, Morin A, Laprise C, Boulet LP. Asthma and rhinitis: what is the relationship? Curr Opin Allergy Clin Immunol. 2012;12:449–54. https://doi.org/10.1097/ACI.0b013e328357cc32.

    5. 5.

      • Saranz RJ, Lozano A, Lozano NA, Ponzio MF, Cruz ÁA. Subclinical lower airways correlates of chronic allergic and non-allergic rhinitis. Clin Exp Allergy. 2017;47:988–97. https://doi.org/10.1111/cea.12938The authors review the lower airway abnormalities in chronic rhinitis.

    6. 6.

      •• Togias A, Gergen PJ, Hu JW, Babineau DC, Wood RA, Cohen RT, et al. Rhinitis in children and adolescents with asthma: ubiquitous, difficult to control, and associated with asthma outcomes. J Allergy Clin Immunol. 2019;143:1003–11. https://doi.org/10.1016/j.jaci.2018.07.041The aim of this excellent investigation was to determine the prevalence of different phenotypes of rhinitis in children and adolescents with asthma.

    7. 7.

      Eriksson J, Bjerg A, Lötvall J, Wennergren G, Rönmark E, Torén K, et al. Rhinitis phenotypes correlate with different symptom presentation and risk factor patterns of asthma. Respir Med. 2011;105:1611–21. https://doi.org/10.1016/j.rmed.2011.06.004.

    8. 8.

      Leynaert B, Bousquet J, Neukirch C, Korobaeff M, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol. 1999;104:301–4.

    9. 9.

      Higuchi O, Adachi Y, Itazawa T, Ito Y, Yoshida K, Ohya Y, et al. Rhinitis has an association with asthma in school children. Am J Rhinol Allergy. 2013;27:e22–5. https://doi.org/10.2500/ajra.2013.27.3846.

    10. 10.

      Chawes BL, Bønnelykke K, Kreiner-Møller E, Bisgaard H. Children with allergic and nonallergic rhinitis have a similar risk of asthma. J Allergy Clin Immunol. 2010;126:567–73. https://doi.org/10.1016/j.jaci.2010.06.026.

    11. 11.

      Leynaert B, Neukirch C, Kony S, Guénégou A, Bousquet J, Aubier M, et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol. 2004;113:86–93. https://doi.org/10.1016/j.jaci.2003.10.010.

    12. 12.

      Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. 1994;15:21–5.

    13. 13.

      Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372:1049–57. https://doi.org/10.1016/S0140-6736(08)61446-4.

    14. 14.

      •• Carr TF, Stern DA, Halonen M, Wright AL, Martinez FD. Non-atopic rhinitis at age 6 isassociated with subsequent development of asthma. Clin Exp Allergy. 2019;49:35–43. https://doi.org/10.1111/cea.13276This is the first longitudinal study that analyzes the evolution of rhinitis to asthma since childhood.

    15. 15.

      Saranz RJ, Lozano A, Lozano NA, Sosa Aguirre AG, Alegre G. Mecanismos de la conexión nariz-pulmón. Methodo. 2017;2:3–15. https://doi.org/10.22529/me.2017.2(1)02.

    16. 16.

      • Kanda A, Kobayashi Y, Asako M, Tomoda K, Kawauchi H, Iwai H. Regulation of interaction between the upper and lower airways in united airway disease. Med Sci (Basel) 2019;7 (2). https://doi.org/10.3390/medsci7020027The last review about the etiology and mechanisms of united airway disease.

    17. 17.

      Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol. 1992;89:611–8.

    18. 18.

      Braunstahl GJ. The unified immune system: respiratory tract—nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol. 2005;115:142–8. https://doi.org/10.1016/j.jaci.2004.10.041.

    19. 19.

      McFadden ER Jr. Nasal-sinus-pulmonary reflexes and bronchial asthma. J Allergy Clin Immunol. 1986;78:1–5.

    20. 20.

      Bardin P, VanHeerden B, Joubert J. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol. 1990;86:82–8.

    21. 21.

      Braunsthal GJ, Overbeek S, KleinJan A, Prins JB, Hoogsteden H, Fokkens W. Nasal allergen provocation induces adhesion molecules expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107:469–76.

    22. 22.

      Braunstahl GJ, Overbeek SE, Fokkens WJ, Kleinjan A, McEuen AR, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med. 2001;164:858–65. https://doi.org/10.1164/ajrccm.164.5.2006082.

    23. 23.

      Kariyawasam HH, Rotiroti G. Allergic rhinitis, chronic rhinosinusitis and asthma: unravelling a complex relationship. Curr Opin Otolaryngol Head Neck Surg. 2013;21:79–86. https://doi.org/10.1097/MOO.0b013e32835ac640.

    24. 24.

      Liu Y, Zeng M, Liu Z. Th17 response and its regulation in inflammatory upper airway diseases. Clin Exp Allergy. 2015;45:602–12. https://doi.org/10.1111/cea.12378.

    25. 25.

      Cheng KJ, Zhou ML, Xu YY, Zhou SH. The role of local allergy in the nasal inflammation. Eur Arch Otorhinolaryngol. 2017;274:3275–81. https://doi.org/10.1007/s00405-017-4640-6.

    26. 26.

      Rondón C, Bogas G, Barrionuevo E, Blanca M, Torres MJ, Campo P. Nonallergic rhinitis and lower airway disease. Allergy. 2017;72:24–34. https://doi.org/10.1111/all.12988.

    27. 27.

      Townley RG, Ryo UY, Kolotkin BM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol. 1975;56:429–42.

    28. 28.

      Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 1977;7:235–43.

    29. 29.

      Ramsdale HE, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyper-responsiveness in rhinitis. J Allergy Clin Immunol. 1985;75:573–7.

    30. 30.

      Braman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM. Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest. 1987;91:671–4.

    31. 31.

      Prieto L, Gutiérrez V, Liñana J, Marín J. Bronchoconstriction induced by inhaled adenosine 5′-monophosphate in subjects with allergic rhinitis. Eur Respir J. 2001;17:64–70.

    32. 32.

      Choi SH, Yoo Y, Yu J, Rhee CS, Min YG, Koh YY. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy. 2007;62:1051–6. https://doi.org/10.1111/j.1398-9995.2007.01403.x.

    33. 33.

      Cirillo I, Pistorio A, Tosca M, Ciprandi G. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity. Allergy. 2009;64:439–44. https://doi.org/10.1111/j.1398-9995.2008.01851.x.

    34. 34.

      Rakkhong K, Kamchaisatian W, Vilaiyuk S, Sasisakulporn C, Teawsomboonkit W, Pornsuriyasak P, et al. Exercise-induced bronchoconstriction in rhinitis children without asthma. Asian Pac J Allergy Immunol. 2011;29:278–83.

    35. 35.

      Kim SW, Han DH, Lee SJ, Lee CH, Rhee CS. Bronchial hyperresponsiveness in pediatric rhinitis patients: the difference between allergic and nonallergic rhinitis. Am J Rhinol Allergy. 2013;27:63–8. https://doi.org/10.2500/ajra.2013.27.3877.

    36. 36.

      Wang Q, Ji J, Xie Y, Guan W, Zhan Y, Wang Z, et al. Lower airway inflammation and hyperresponsiveness in nonasthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015;7:1756–64. https://doi.org/10.3978/j.issn.2072-1439.2015.10.26.

    37. 37.

      Karaatmaca B, Gur Cetinkaya P, Esenboga S, Ozer M, Soyer O, Karabulut E, et al. Bronchial hyperresponsiveness in children with allergic rhinitis and the associated risk factors. Allergy. 2019. https://doi.org/10.1111/all.13755.

    38. 38.

      Prieto L, Gutiérrez V, Morales C, Perpinan J, Inchaurraga I. Variability of peak flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing. Ann Allergy Asthma Immunol. 1998;80:151–8.

    39. 39.

      Koh YY, Kang EK, Min YG, Kim CK. The importance of maximal airway response to methacholine in the prediction of asthma development in patients with allergic rhinitis. Clin Exp Allergy. 2002;32:921–7. https://doi.org/10.1046/j.1365-2222.2002.01399.x.

    40. 40.

      •• Haccuria A, Van Muylem A, Malinovschi A, Doan V, Michils A. Small airways dysfunction: the link between allergic rhinitis and allergic asthma. Eur Respir J. 2018;51:1701749. https://doi.org/10.1183/13993003.01749-2017This paper provides evidence of small airway dysfunction in patients with allergic rhinitis.

    41. 41.

      Ciprandi G, Tosca MA, Signori A, Cirillo I. Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor. Allergy Asthma Proc. 2011;32:4–8. https://doi.org/10.2500/aap.2011.32.3425.

    42. 42.

      Ciprandi G, Cirillo I, Pistorio A. Impact of allergic rhinitis on asthma: effects on spirometric parameters. Allergy. 2008;63:255–60. https://doi.org/10.1111/j.1398-9995.2007.01544.x.

    43. 43.

      Kessel A, Halloun H, Bamberger E, Kugelman A, Toubi E. Abnormal spirometry in children with persistent allergic rhinitis due to mite sensitization: the benefit of nasal corticosteroids. Pediatr Allergy Immunol. 2008;19:61–6. https://doi.org/10.1111/j.1399-3038.2007.00588.x.

    44. 44.

      Ciprandi G, Capasso M. Association of childhood perennial allergic rhinitis with subclinical airflow limitation. Clin Exp Allergy. 2010;40:398–402. https://doi.org/10.1111/j.1365-2222.2009.03399.x.

    45. 45.

      Ciprandi G, Signori A, Tosca MA, Cirillo I. Bronchodilation test in patients with allergic rhinitis. Allergy. 2011;66:694–8. https://doi.org/10.1111/j.1398-9995.2011.02544.x.

    46. 46.

      Ianiero L, Saranz RJ, Lozano NA, Lozano A, Sasia LV, Ramírez M, et al. Análisis de la curva flujo-volumen en niños y adolescentes con rinitis alérgica sin asma. Arch Argent Pediatr. 2013;111:322–7. https://doi.org/10.5546/aap.2013.322.

    47. 47.

      Saranz RJ, Lozano A, Valero A, Lozano NA, Bovina Martijena MD, Agresta F, et al. Impact of rhinitis on lung function in children and adolescents without asthma. Allergol Immunopathol (Madr). 2016;44:556–62. https://doi.org/10.1016/j.aller.2016.04.006.

    48. 48.

      Kim YH, Park HB, Kim MJ, Kim HS, Lee HS, Han YK, et al. Fractional exhaled nitric oxide and impulse oscillometry in children with allergic rhinitis. Allergy, Asthma Immunol Res. 2014;6:27–32. https://doi.org/10.4168/aair.2014.6.1.27.

    49. 49.

      •• Skylogianni E, Triga M, Douros K, Bolis K, Priftis KN, Fouzas S, et al. Small-airway dysfunction precedes the development of asthma in children with allergic rhinitis. Allergol Immunpathol. 2018;46:313–2. https://doi.org/10.1016/j.aller.2017.09.025This study suggests that changes in respiratory impedance in children with allergic rhinitis might help to predict progression to asthma.

    50. 50.

      Capasso M, Varricchio A, Ciprandi G. Impact of allergic rhinitis on asthma in children: effects on bronchodilation test. Allergy. 2010;65:264–8.

    51. 51.

      Foresi A, Leone C, Pelucchi A, Mastropasqua B, Chetta A, D’Ippolito R, et al. Eosinophils, mast cells and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacoline responsiveness. J Allergy Clin Immunol. 1997;100:58–64.

    52. 52.

      Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy. 2006;61:111–8. https://doi.org/10.1111/j.1398-9995.2006.00967.x.

    53. 53.

      Makris MP, Gratziou C, Aggelides XS, Koulouris SP, Koti I, Kalogeromitros DC, et al. Exhaled nitric oxide, bronchial hyper-responsiveness and spirometric parameters in patients with allergic rhinitis during pollen season. Iran J Allergy Asthma Immunol. 2011;10:251–60 010.04/ijaai.251260.

    54. 54.

      Kalpaklioglu AF, Kalkan IK. Comparison of orally exhaled nitric oxide in allergic versus non-allergic rhinitis. Am J Rhinol Allergy. 2012;26:e50–4. https://doi.org/10.2500/ajra.2012.26.3717.

    55. 55.

      Panzner P, Malkusová I, Vachová M, Liska M, Brodská P, Růžičková O, et al. Bronchial inflammation in seasonal allergic rhinitis with or without asthma in relation to natural exposure to pollen allergen. Allergol Immunopathol (Madr). 2015;43:3–9. https://doi.org/10.1016/j.aller.2013.06.009.

    56. 56.

      Wang W, Xian M, Xie Y, Zheng J, Li J. Aggravation of airway inflammation and hyper-responsiveness following nasal challenge with Dermatophagoides pteronyssinus in perennial allergic rhinitis without symptoms of asthma. Allergy. 2016;71:378–86. https://doi.org/10.1111/all.12808.

    57. 57.

      Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–15. https://doi.org/10.1164/rccm.9120-11ST.

    58. 58.

      Ciprandi G, Ricciardolo FLM, Schiavetti I, Cirillo I. Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine. Am J Rhinol Allergy. 2014;18:e214–8. https://doi.org/10.2500/ajra.2014.28.4124.

    59. 59.

      Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology. Allergy Asthma Proc. 2014;35:357–61. https://doi.org/10.2500/aap.2014.35.3794.

    60. 60.

      Xia S, Zhu Z, Guan WJ, Xie YQ, An JY, Peng T, et al. Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: a comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma. Exp Ther Med. 2018;15:1761–7. https://doi.org/10.3892/etm.2017.5536.

    61. 61.

      Choi BS, Kim KW, Lee YJ, Baek J, Park HB, Kim YH, et al. Exhaled nitric oxide is associated with allergic inflammation in children. J Korean Med Sci. 2011;26:1265–9. https://doi.org/10.3346/jkms.2011.26.10.1265.

    62. 62.

      Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodeling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73:993–1002. https://doi.org/10.1111/all.13373.

    63. 63.

      Chen ZY, Zhou SH, Zhou QF, Tang HB. Inflammation and airway remodeling of the lung in guinea pigs with allergic rhinitis. Exp Ther Med. 2017;14:3485–90. https://doi.org/10.3892/etm.2017.4937.

    64. 64.

      Yılmaz I, Bayraktar N, Ceyhan K, Seçil D, Yüksel S, Mısırlıgil Z, et al. Evaluation of vascular endothelial growth factor A and endostatin levels in induced sputum and relationship to bronchial hyperreactivity in patients with seasonal allergic rhinitis. Am J Rhinol Allergy. 2013;27:181–6. https://doi.org/10.2500/ajra.2013.27.3867.

    65. 65.

      Yang MS, Lee HA, Kim MH, Song WJ, Kim TW, Kwon JW, et al. Rhinitis patients with sputum eosinophilia show decreased lung function in the absence of airway hyperresponsiveness. Allergy, Asthma Immunol Res. 2013;5:232–8. https://doi.org/10.4168/aair.2013.5.4.232.

    66. 66.

      Prieto L, Bertó JM, Gutierrez V. Airway responsiveness to methacholine and risk of asthma in patients with allergic rhinitis. Ann Allergy. 1994;72:534–9.

    67. 67.

      Añibarro B, García-Ara MC, Díaz MF, Boyano T, Ojeda JA. Nonspecific bronchial hyperresponsiveness and development of asthma in children with hay fever. Pediatr Allergy Immunol. 1995;6:200–3.

    68. 68.

      Ferdousi HA, Zetterstrom O, Dreborg S. Bronchial hyperresponsiveness predicts the development of mild clinical asthma within 2 yr in school children with hay-fever. Pediatr Allergy Immunol. 2005;16:478–86. https://doi.org/10.1111/j.1399-3038.2005.00296.x.

    69. 69.

      Di Cara G, Marcucci F, Palomba A, Milioni M, Pecoraro L, Ciprandi G, et al. Exhaled nitric oxide in children with allergic rhinitis: a potential biomarker of asthma development. Pediatr Allergy Immunol. 2014;26:85–7. https://doi.org/10.1111/pai.12326.

    70. 70.

      • Ciprandi G, Gallo F, Ricciardolo FL, Cirillo I. Fractional exhaled nitric oxide: a potential biomarker in allergic rhinitis? Int Arch Allergy Immunol. 2017;172:99–105. https://doi.org/10.1159/000456548This study highlights the relevance of FeNO in allergic rhinitis patients as a possible predictive marker for asthma development.

    71. 71.

      Lee E, Lee SH, Kwon JW, Kim Y, Cho HJ, Yang SI, et al. A rhinitis phenotype associated with increased development of bronchial hyperresponsiveness and asthma in children. Ann Allergy Asthma Immunol. 2016;117:21–8. https://doi.org/10.1016/j.anai.2016.04.016.

    72. 72.

      Ciprandi G, Tosca MA, Capasso M. High exhaled nitric oxide levels may predict bronchial reversibility in allergic children with asthma or rhinitis. J Asthma. 2013;50:33–8. https://doi.org/10.3109/02770903.2012.740119.

    73. 73.

      •• Valverde-Molina J. From rhinitis to asthma: is small airway disfunction the clue? Allergol Immunopathol (Madr). 2018;46:311–2. https://doi.org/10.1016/j.aller.2018.06.001This is an excellent editorial about the support of small airway disease as the link between allergic rhinitis and asthma.

    74. 74.

      Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy. 2011;66:596–604. https://doi.org/10.1111/j.1398-9995.2010.02534.x.

    75. 75.

      Andiappan AK, Nilsson D, Halldén C, Yun WD, Säll T, Cardell LO, et al. Investigating highly replicated asthma genes as candidate genes for allergic rhinitis. BMC Med Genet. 2013;14:51. https://doi.org/10.1186/1471-2350-14-51.

    76. 76.

      Li J, Zhanga Y, Zhanga L. Discovering susceptibility genes for allergic rhinitis and allergy using a genome-wide association study strategy. Curr Opin Allergy Clin Immunol. 2015;15:33–40. https://doi.org/10.1097/ACI.0000000000000124.

    77. 77.

      Aguilar D, Pinart M, Koppelman GH, Saeys Y, Nawijn MC, Postma DS, et al. Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017;12:e0179125. https://doi.org/10.1371/journal.pone.0179125.

    78. 78.

      Harb H, Renz H. Update on epigenetics in allergic disease. J Allergy Clin Immunol. 2015;135:15–24. https://doi.org/10.1016/j.jaci.2014.11.009.

    79. 79.

      Man WH, de Steenhuijsen Piters WA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017;15:259–70. https://doi.org/10.1038/nrmicro.2017.14.

    80. 80.

      • Ta LDH, Yap GC, Tay CJX, Lim ASM, Huang CH, Chu CW, et al. Establishment of the nasal microbiota in the first 18 months of life: correlation with early-onset rhinitis and wheezing. J Allergy Clin Immunol. 2018;142:86–95. https://doi.org/10.1016/j.jaci.2018.01.032The results or this article support the hypothesis that the characteristic of nasal microbiota affects development of early-onset rhinitis and wheeze in infants.

    81. 81.

      Sozańska B. Microbiome in the primary prevention of allergic diseases and bronchial asthma. Allergol Immunopathol (Madr). 2019;47:79–84. https://doi.org/10.1016/j.aller.2018.03.005.

    82. 82.

      Ober C, Sperling AI, von Mutius E, Vercelli D. Immune development and environment: lessons from Amish and Hutterite children. Curr Opin Immunol. 2017;48:51–60. https://doi.org/10.1016/j.coi.2017.08.003.

    83. 83.

      Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, et al. Innate immunity and asthma risk in amish and hutterite farm children. N Engl J Med. 2016;375:411–21. https://doi.org/10.1056/NEJMoa1508749.

    84. 84.

      Tsilochristou OA, Douladiris N, Makris M, Papadopoulos NG. Pediatric allergic rhinitis and asthma: can the march be halted? Paediatr Drugs. 2013;15:431–40. https://doi.org/10.1007/s40272-013-0043-3.

    85. 85.

      •• Morjaria JB, Caruso M, Emma R, Russo C, Polosa R. Treatment of allergic rhinitis as a strategy for preventing asthma. Curr Allergy Asthma Rep. 2018;18:23. https://doi.org/10.1007/s11882-018-0781-yThe last review about how the treatment of rhinitis, mainly with allergen immunotherapy, may prevent asthma onset.

    86. 86.

      Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68:569–79. https://doi.org/10.1111/all.12124.

    87. 87.

      Kessel A. The impact of intranasal corticosteroids on lung function in children with allergic rhinitis. Pediatr Pulmonol. 2014;49:932–7. https://doi.org/10.1002/ppul.22912.

    88. 88.

      Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone priopionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol. 1996;98:274–82.

    89. 89.

      Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR. Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol. 2003;111:313–20.

    90. 90.

      Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466–76. https://doi.org/10.1016/j.jaci.2010.06.047.

    91. 91.

      Grembiale RD, Camporora Naty S, Tranfa CME, Djukanovic R, Mársico SA. Effect of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;162:2048–52. https://doi.org/10.1164/ajrccm.162.6.9909087.

    92. 92.

      Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, Halken S, Høst A, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62:943–8. https://doi.org/10.1111/j.1398-9995.2007.01451.x.

    93. 93.

      Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004;114:851–7. https://doi.org/10.1016/j.jaci.2004.07.012.

    94. 94.

      Marogna M, Tomassetti D, Bernasconi A, Colombo F, Massolo A, Businco ADR, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol. 2008;101:206–11.

    95. 95.

      Valovirta E, Petersen TH, Piotrowska T, Laursen MK, Andersen JS, Sørensen HF, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141:529–38.e13. https://doi.org/10.1016/j.jaci.2017.06.014.

    96. 96.

      •• Kristiansen M, Dhami S, Netuveli G, Halken S, Muraro A, Roberts G, et al. Allergen immunotherapy for the prevention of allergy: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28:18–29. https://doi.org/10.1111/pai.12661This is a meta-analysis about the role of allergen immunotherapy for the prevention of allergic diseases.

    97. 97.

      Muraro A, Lemanske RF Jr, Hellings PW, Akdis CA, Bieber T, Casale TB, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137:1347–58. https://doi.org/10.1016/j.jaci.2016.03.010.

    98. 98.

      Weinstein SF, Katial R, Jayawardena S, Pirozzi G, Staudinger H, Eckert L, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142:171–7.e1. https://doi.org/10.1016/j.jaci.2017.11.051.

    99. 99.

      • Heffler E, Brussino L, Del Giacco S, Paoletti G, Minciullo PL, Varricchi G, et al. New drugs in early-stage clinical trials for allergic rhinitis. Expert Opin Investig Drugs. 2019;28:267–73. https://doi.org/10.1080/13543784.2019.1571581Interesting data about the state of the art of novel drugs for therapeutic approach to rhinitis.

    Download references

    Author information

    Correspondence to Ricardo J. Saranz MD.

    Ethics declarations

    Conflict of Interest

    Ricardo Saranz declares that he has no conflict of interest. Alejandro Lozano declares that he has no conflict of interest. Natalia Lozano declares that she has no conflict of interest. Graciela Alegre declares that she has no conflict of interest. Marina Ponzio Biol declares that she has no conflict of interest.

    Human and Animal Rights and Informed Consent

    This article does not contain any studies with human or animal subjects performed by any of the authors.

    Additional information

    Publisher’s Note

    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    This article is part of the Topical Collection on Allergic Rhinitis

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Saranz, R.J., Lozano, A., Lozano, N.A. et al. The Roadmap From Allergic Rhinitis to Asthma. Curr Treat Options Allergy (2020) doi:10.1007/s40521-020-00245-z

    Download citation

    Keywords

    • Rhinitis
    • Lung function tests
    • Bronchial hyper-reactivity
    • Airway remodeling
    • Allergic march
    • Genetic linkage analyses